Labastida, Mary Joy .
HRN: 23-88-31 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2023
CEFUROXIME 500MG (TAB)
10/10/2023
10/17/2023
PO
500 Mg
BID
UTI
Waiting Final Action